Natures Sunshine Products Inc (NATR) stock
NATRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 16/3058% below fair value
$10.32−0.01 (-0.10%)
Close on Nov 18, 2026Market cap $181.59MP/E 10.2Yield –
Natures Sunshine Products operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Natures Sunshine Products's operating income for the twelve months ending Jun 30, 2026 was $29.32M, up 44.6% year over year. For fiscal 2025 it was $24.74M, up 23.1% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is $34.67M in fiscal 2021.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.74M | +23.1% |
| FY2024 | Dec 31, 2024 | $20.10M | +7.2% |
| FY2023 | Dec 31, 2023 | $18.75M | +15.3% |
| FY2022 | Dec 31, 2022 | $16.26M | -53.1% |
| FY2021 | Dec 31, 2021 | $34.67M | +61.4% |
| FY2020 | Dec 31, 2020 | $21.48M | +33.2% |
| FY2019 | Dec 31, 2019 | $16.13M | +201.3% |
| FY2018 | Dec 31, 2018 | $5.35M | +285.8% |
| FY2017 | Dec 31, 2017 | $1.39M | -86.2% |
| FY2016 | Dec 31, 2016 | $10.04M | -27.6% |
| FY2015 | Dec 31, 2015 | $13.87M | -27.2% |
| FY2014 | Dec 31, 2014 | $19.05M | -19.2% |
| FY2013 | Dec 31, 2013 | $23.58M | -30.4% |
| FY2012 | Dec 31, 2012 | $33.87M | +67.9% |
| FY2011 | Dec 31, 2011 | $20.17M | +79.0% |
| FY2010 | Dec 31, 2010 | $11.26M | -9.4% |
| FY2009 | Dec 31, 2009 | $12.43M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.48M | +28.2% |
| Q1 FY2026 | Mar 31, 2026 | $9.55M | +54.7% |
| Q4 FY2025 | Dec 31, 2025 | $5.32M | +17.0% |
| Q3 FY2025 | Sep 30, 2025 | $8.98M | +69.9% |
| Q2 FY2025 | Jun 30, 2025 | $4.27M | -24.2% |
| Q1 FY2025 | Mar 31, 2025 | $6.17M | +33.5% |
| Q4 FY2024 | Dec 31, 2024 | $4.55M | -20.3% |
| Q3 FY2024 | Sep 30, 2024 | $5.28M | -9.4% |
| Q2 FY2024 | Jun 30, 2024 | $5.64M | -19.9% |
| Q1 FY2024 | Mar 31, 2024 | $4.62M | +2588.4% |
| Q4 FY2023 | Dec 31, 2023 | $5.71M | +36.5% |
| Q3 FY2023 | Sep 30, 2023 | $5.83M | +16.4% |
| Q2 FY2023 | Jun 30, 2023 | $7.04M | +22.3% |
| Q1 FY2023 | Mar 31, 2023 | $172.00K | -86.9% |
| Q4 FY2022 | Dec 31, 2022 | $4.18M | -44.6% |
| Q3 FY2022 | Sep 30, 2022 | $5.01M | -49.9% |
| Q2 FY2022 | Jun 30, 2022 | $5.76M | -39.3% |
| Q1 FY2022 | Mar 31, 2022 | $1.31M | -82.9% |
| Q4 FY2021 | Dec 31, 2021 | $7.54M | +235.4% |
| Q3 FY2021 | Sep 30, 2021 | $10.01M | +82.9% |
| Q2 FY2021 | Jun 30, 2021 | $9.49M | +43.7% |
| Q1 FY2021 | Mar 31, 2021 | $7.64M | +6.6% |
| Q4 FY2020 | Dec 31, 2020 | $2.25M | -42.5% |
| Q3 FY2020 | Sep 30, 2020 | $5.47M | +16.4% |
| Q2 FY2020 | Jun 30, 2020 | $6.60M | +45.4% |
| Q1 FY2020 | Mar 31, 2020 | $7.16M | +140.5% |
| Q4 FY2019 | Dec 31, 2019 | $3.91M | – |
| Q3 FY2019 | Sep 30, 2019 | $4.70M | +33.8% |
| Q2 FY2019 | Jun 30, 2019 | $4.54M | +107.6% |
| Q1 FY2019 | Mar 31, 2019 | $2.98M | +238.0% |
| Q4 FY2018 | Dec 31, 2018 | -$1.23M | – |
| Q3 FY2018 | Sep 30, 2018 | $3.51M | +63.1% |
| Q2 FY2018 | Jun 30, 2018 | $2.19M | +9404.3% |
| Q1 FY2018 | Mar 31, 2018 | $881.00K | -57.0% |
| Q4 FY2017 | Dec 31, 2017 | -$2.84M | – |
| Q3 FY2017 | Sep 30, 2017 | $2.15M | -57.4% |
| Q2 FY2017 | Jun 30, 2017 | $23.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $2.05M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.39M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.06M | – |
See a number that looks wrong?